Literature DB >> 7554184

Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up.

A Maes1, F Van de Werf, J Nuyts, G Bormans, W Desmet, L Mortelmans.   

Abstract

BACKGROUND: Impaired tissue reperfusion after successful recanalization of an epicardial coronary artery has been documented both in animals and in patients with acute myocardial infarction. Whether this phenomenon can be demonstrated with positron emission tomography (PET) and whether it has an effect on late recovery of flow, metabolism, and function are unknown. METHODS AND
RESULTS: Thirty patients with an acute myocardial infarction and TIMI flow grade 3 of the infarcted vessel at 90 minutes after thrombolytic therapy were studied. Within 24 hours after thrombolysis, at 5 days and at 3 months, myocardial blood flow was measured with 13NH3. 18FDG uptake was measured at 5 days. Radionuclide left ventricular angiograms were acquired at 5 days and at 3 months. In 11 patients (37%), regional myocardial flow was severely impaired (< 50% of normally perfused myocardium) despite successful thrombolysis. No recovery of left ventricular function occurred in any of these patients at 3 months. In 12 patients (40%), intermediate flows (50% to 75% of normal) were found, with functional improvement after angioplasty only in regions with a PET mismatch. Seven patients (23%) had high flow values early after successful thrombolysis (> 75% of normal) and showed preserved regional contractile function at 3 months.
CONCLUSIONS: This study is the first demonstration with PET of impaired myocardial tissue perfusion in patients with an acute myocardial infarction after successful thrombolysis. Functional recovery of the reperfused myocardium is observed only when adequate tissue flow is restored. PET may be helpful in selecting patients in whom additional revascularization can improve recovery of left ventricular function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554184     DOI: 10.1161/01.cir.92.8.2072

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

Review 1.  PET radiopharmaceuticals used in viability studies in acute myocardial infarction: a literature survey.

Authors:  Liesbet Mesotten; Alex Maes; Frans Van de Werf; Luc Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2001-11-14       Impact factor: 9.236

2.  PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting.

Authors:  Heinrich R Schelbert; Robert Beanlands; Frank Bengel; Juhani Knuuti; Marcelo Dicarli; Josef Machac; Randolph Patterson
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

3.  Primary PTCA: Possibly the Best, Often the Only Choice for Reperfusion in Acute Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 4.  Non-invasive imaging of microvascular damage.

Authors:  L Galiuto; L Natale; L Leccisotti; G Locorotondo; A Giordano; L Bonomo; F Crea
Journal:  J Nucl Cardiol       Date:  2009-08-25       Impact factor: 5.952

5.  Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion/F-18-FDG PET during the sub-acute phase following reperfusion of acute anterior myocardial infarction.

Authors:  Daniel D Anselm; Anjali H Anselm; Jennifer Renaud; Harold L Atkins; Robert de Kemp; Ian G Burwash; Kathryn A Williams; Ann Guo; Cathy Kelly; Jean Dasilva; Rob S B Beanlands; Christopher A Glover
Journal:  J Nucl Cardiol       Date:  2011-05-13       Impact factor: 5.952

Review 6.  Pathophysiology of myocardial injury and remodeling: implications for molecular imaging.

Authors:  Jennifer A Dixon; Francis G Spinale
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

7.  Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.

Authors:  Haruhisa Shirasaki; Akira Nakano; Hiroyasu Uzui; Yoshiharu Yonekura; Hidehiko Okazawa; Takanori Ueda; Jong-Dae Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-04       Impact factor: 9.236

8.  Relation between different methods for analysing ST segment deviation and infarct size as assessed by positron emission tomography.

Authors:  W J Desmet; L V Mesotten; A F Maes; H P Heidbüchel; L A Mortelmans; F J Van de Werf
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 9.  Pharmacologic reperfusion therapy for acute myocardial infarction.

Authors:  Harry C Lowe; Briain D Mac Neill; Frans Van de Werf; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

10.  Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction.

Authors:  C Michael Gibson; James A de Lemos; Sabina A Murphy; Susan J Marble; Kent W Dauterman; Andrew Michaels; Hal V Barron; Elliott M Antman
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.